Tesamorelin

Tesamorelin is a synthetic GHRH analog studied for growth hormone release, IGF-1 signaling, body-composition changes, and visceral fat research. It stimulates the pituitary through GHRH receptor pathways, making it useful for examining regulated GH-axis activation. Research interest often focuses on metabolic markers, abdominal adiposity, lipid handling, and endocrine changes associated with GH stimulation. Tesamorelin differs from broad GH replacement models because it acts upstream through a releasing-hormone mechanism. Scientists study it to understand how targeted GHRH analog activity influences fat distribution, metabolic function, and hormone-regulated tissue remodeling.